Pharmaceuticals: Other
French companies producing specialized pharmaceuticals
Firms in this secondary pharmaceutical group focus on niche therapeutics, animal health products, or specialized clinical compounds. Specific patent rulings and localized regulatory approvals inject sudden volatility into these stocks. Right now, Biophytis SA tops both trading volume and price growth. You can find more fundamental and technical metrics in the table below.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 ABVXAbivax SA | 6.96 B EUR | 77.15 EUR | −0.64% | 161.37 K | 1.57 | — | −5.23 EUR | −59.53% | 0.00% | Health technology | Strong buy |
 BOIBoiron SA | 333.73 M EUR | 19.90 EUR | +2.05% | 4.25 K | 1.16 | 13.19 | 1.51 EUR | +35.22% | 7.09% | Health technology | No rating |
| AALN4N4 Group | 257.92 M EUR | 23.170 EUR | +0.46% | 1.06 K | — | — | — | — | — | Health technology | No rating |
 ABAB Science SA | 50.97 M EUR | 0.506 EUR | −3.98% | 502.5 K | 7.03 | — | −0.08 EUR | +44.01% | 0.00% | Health technology | No rating |
 ALBPSBiophytis SA | 15.31 M EUR | 0.0424 EUR | +5.47% | 39.88 M | 1.09 | — | — | — | 0.00% | Health technology | Strong buy |
 ALVINVinpai S.A. | 13.32 M EUR | 2.84 EUR | −2.74% | 357 | 3.73 | — | — | — | — | Health technology | No rating |
 ALRGRRougier SA | 12.01 M EUR | 11.1 EUR | 0.00% | 1 | 0.31 | — | −8.13 EUR | −5,742.47% | 0.00% | Health technology | No rating |